Healthcare provider profile · identity verified

Pierre A Caron, MD

Family Practice · WARWICK, RI · NPI 1871588947

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	409	198
Amlodipine Besylate	Amlodipine Besylate	236	112
Lisinopril	Lisinopril	203	105
Levothyroxine Sodium	Levothyroxine Sodium	196	84
Omeprazole	Omeprazole	178	93
Losartan Potassium	Losartan Potassium	146	77
Metoprolol Succinate	Metoprolol Succinate	120	63
Metformin Hcl	Metformin Hcl	118	53
Rosuvastatin Calcium	Rosuvastatin Calcium	115	51
Hydrochlorothiazide	Hydrochlorothiazide	109	61
Gabapentin	Gabapentin	94	37
Furosemide	Furosemide	88	41
Trazodone Hcl	Trazodone Hcl	87	37
Eliquis	Apixaban	86	29
Montelukast Sodium	Montelukast Sodium	74	33
Fluticasone Propionate	Fluticasone Propionate	69	39
Sertraline Hcl	Sertraline Hcl	66	26
Pantoprazole Sodium	Pantoprazole Sodium	64	26
Simvastatin	Simvastatin	64	37
Tamsulosin Hcl	Tamsulosin Hcl	64	32
Alendronate Sodium	Alendronate Sodium	61	32
Albuterol Sulfate Hfa	Albuterol Sulfate	58	30
Famotidine	Famotidine	58	20
Lorazepam	Lorazepam	55	19
Metoprolol Tartrate	Metoprolol Tartrate	55	31
Pravastatin Sodium	Pravastatin Sodium	53	28
Potassium Chloride	Potassium Chloride	45	22
Meloxicam	Meloxicam	43	18
Allopurinol	Allopurinol	39	16
Carvedilol	Carvedilol	39	16
Glimepiride	Glimepiride	39	19
Jardiance	Empagliflozin	39	15
Metformin Hcl Er	Metformin Hcl	39	22
Escitalopram Oxalate	Escitalopram Oxalate	37	18
Fluoxetine Hcl	Fluoxetine Hcl	37	16
Quetiapine Fumarate	Quetiapine Fumarate	35	14
Glipizide	Glipizide	34	14
Citalopram Hbr	Citalopram Hydrobromide	31	18
Venlafaxine Hcl Er	Venlafaxine Hcl	31	15
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	14
Ezetimibe	Ezetimibe	29	14
Mirtazapine	Mirtazapine	29	11
Finasteride	Finasteride	28	15
Ozempic	Semaglutide	27	suppressed
Atenolol	Atenolol	26	17
Tramadol Hcl	Tramadol Hcl	26	suppressed
Alprazolam	Alprazolam	25	15
Azithromycin	Azithromycin	25	23
Ibuprofen	Ibuprofen	24	12
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Colchicine	Colchicine	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Hydrocortisone	Hydrocortisone	18	11
Irbesartan	Irbesartan	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	15
Memantine Hcl	Memantine Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Digoxin	Digoxin	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Spironolactone	Spironolactone	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error